Company Profiles

driven by the PitchBook Platform

Abide Therapeutics

Description

Developer of serine hydrolase inhibitor. The company focuses on developing medicines that target serine hydrolases, one of the largest enzyme classes in nature with validated but mostly untapped therapeutic potential.

2011

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$2.2M

Total Amount Raised

1

Investors

Description

Developer of serine hydrolase inhibitor. The company focuses on developing medicines that target serine hydrolases, one of the largest enzyme classes in nature with validated but mostly untapped therapeutic potential.

Website:

www.abidetx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

10835 Road to the Cure Suite 250 San Diego, CA 92121United States +1 (858) 427-2590
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Abide Therapeutics's full profile, request a free trial.

Abide Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Abide Therapeutics Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cardinal PartnersVenture CapitalMinority000 0000000 0000
Cardinal Partners Venture Capital

Abide Therapeutics Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Cheryl Grice Ph.DVice President, Chemistry
Iain Fraser Ph.DVice President, Early Clinical Development
Chan BealsChief Medical Officer
Stan BlackburnChief Financial Officer
Alan Ezekowitz Ph.DCo-Founder, Board Member, President & Chief Executive Officer
Cheryl Grice Ph.D Vice President, Chemistry
Iain Fraser Ph.D Vice President, Early Clinical Development
Chan Beals Chief Medical Officer
Stan Blackburn Chief Financial Officer
Alan Ezekowitz Ph.D Co-Founder, Board Member, President & Chief Executive Officer

Abide Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Alan Ezekowitz Ph.DAbide TherapeuticsCo-Founder, Board Member, President & Chief Executive Officer000 0000
Benjamin Cravatt Ph.DAbide TherapeuticsCo-Founder, Scientific Advisory Board & Board Member000 0000
John ClarkeCardinal PartnersCo-Founder & Managing General Partner000 0000
Keith LendenSelfCo-Founder & Board Observer000 0000
Nancy ThornberrySelfBoard Member000 0000
Alan Ezekowitz Ph.D Co-Founder, Board Member, President & Chief Executive Officer Abide Therapeutics
Benjamin Cravatt Ph.D Co-Founder, Scientific Advisory Board & Board Member Abide Therapeutics
John Clarke Co-Founder & Managing General Partner Cardinal Partners
Keith Lenden Co-Founder & Board Observer Self
Nancy Thornberry Board Member Self
Request full access to PitchBook